SarnakM., LeveyA.Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis2000; 35(suppl 1): S117–31.
2.
ZimmermannJ., HerrlingerS., PruyA., MetzgerT., WannerC.Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int1999; 55: 648–58.
3.
Kalantar-ZadehK., KoppleJ.D., BlockG., HumphreysM.H.A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis2001; 38: 1251–63.
4.
AriciM., WallsJ.End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?Kidney Int2001; 59: 407–14.
5.
BlacherJ., GuerinA.P., PannierB., MarchaisS.J., SafarM.E., LondonG.M.Impact of aortic stiffness on survival in endstage renal disease. Circulation1999; 99: 2434–9.
6.
BlacherJ., SafarM.E., GuerinA.P., PannierB., MarchaisS.J., LondonG.M.Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int2003; 63: 1852–60.
7.
GuerinA.P., BlacherJ., PannierB., MarchaisS.J., SafarM.E., LondonG.M.Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation2001; 20: 987–92.
8.
LaurentS., BoutouyrieP., AsmarR., GautierI., LalouxB., GuizeL., DucimetiereP., BenetosA.Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension2001; 37: 1236–41.
9.
BlacherJ., DemuthK., GuerinA.P., SafarM.E., MoattiN., LondonG.M.Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol1998; 18: 535–41.
10.
Tycho VuurmansJ.L., BoerW.H., BosW.J., BlankestijnP.J., KoomansH.A.Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol2002; 13: 177–83.
ZoccaliC., BenedettoF.A., MaasR., MallamaciF., TripepiG., MalatinoL.S., BogerR; CREED Investigators. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol2002; 13: 490–6.
14.
BortolottoL.A., SafarM.E., BillaudE., LacroixC., AsmarR., LondonG.M., BlacherJ.Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension1999; 34: 837–42.
15.
LondonG.M., MarchaisS.J., GuerinA.P., MetivierF., AddaH., PannierB.Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. Kidney Int2003; 84(suppl): S88–93.
16.
GuerinA.P., LondonG.M., MarchaisS.J., MetivierF.Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant2000; 15: 1014–21.
17.
TaquetA., Bonithon-KoppC., SimonA., LevensonJ., ScarabinY., MalmejacA., DucimetiereP., GuizeL.Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol1993; 9: 298–306.
18.
RibeiroL., GamaG., SantosA., AsmarR., MartinsL., PoloniaJ.Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: Comparison with normotensives and sustained hypertensives. Blood Press Monit2000; 5: 11–7.
19.
PannierB.M., CambillauM.S., VellaudV., AtgerV., MoattiN., SafarM.E.Abnormalities of lipid metabolism and arterial rigidity in young subjects with borderline hypertension. Clin Invest Med1994; 17: 42–51.
20.
TanakaH., DeSouzaC.A.Seals DR. Absence of age-related increase in central arterial stiffness in physically active women. Arterioscler Thromb Vasc Biol1998; 18: 127–32.
